Haemonetics Corporation (HAE) Q1 2016 Earnings Results

Haemonetics Corp Beats on EPS, Stock Down 1.06%

Haemonetics Corp reported a better-than-expected EPS, which indicates some operational strength. However, the stock fell by 1.06%, likely due to the lack of revenue details and guidance. Investors may be concerned about future growth prospects given the absence of specific forward-looking statements.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.35	N/A	+6.06%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's direction. They emphasized the importance of operational improvements and innovation.

Management highlighted ongoing efforts to improve operational efficiency.

They noted a focus on innovation to drive future growth.

Haemonetics Corp Beats on EPS, Stock Down 1.06%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Beats on EPS, Stock Down 1.06%

Key numbers

Management commentary